ATE173023T1 - Dna-sequenzen kodierend für das polypeptid gelonin - Google Patents

Dna-sequenzen kodierend für das polypeptid gelonin

Info

Publication number
ATE173023T1
ATE173023T1 AT92919264T AT92919264T ATE173023T1 AT E173023 T1 ATE173023 T1 AT E173023T1 AT 92919264 T AT92919264 T AT 92919264T AT 92919264 T AT92919264 T AT 92919264T AT E173023 T1 ATE173023 T1 AT E173023T1
Authority
AT
Austria
Prior art keywords
gelonin
dna sequences
polypeptide
sequences coding
synthetic gene
Prior art date
Application number
AT92919264T
Other languages
English (en)
Inventor
Michael G Rosenblum
Kenneth L Beattie
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE173023T1 publication Critical patent/ATE173023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT92919264T 1991-09-06 1992-08-21 Dna-sequenzen kodierend für das polypeptid gelonin ATE173023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06

Publications (1)

Publication Number Publication Date
ATE173023T1 true ATE173023T1 (de) 1998-11-15

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919264T ATE173023T1 (de) 1991-09-06 1992-08-21 Dna-sequenzen kodierend für das polypeptid gelonin

Country Status (18)

Country Link
US (1) US5624827A (de)
EP (1) EP0602144B1 (de)
JP (1) JPH06510431A (de)
KR (1) KR100270195B1 (de)
CN (1) CN1047402C (de)
AT (1) ATE173023T1 (de)
AU (1) AU679427B2 (de)
CA (1) CA2115049C (de)
DE (1) DE69227519T2 (de)
DK (1) DK0602144T3 (de)
ES (1) ES2123008T3 (de)
FI (1) FI113547B (de)
IL (1) IL103057A (de)
NO (1) NO317659B1 (de)
NZ (1) NZ244220A (de)
RU (1) RU2142015C1 (de)
WO (1) WO1993005168A1 (de)
ZA (1) ZA926705B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
JP4157160B2 (ja) * 1991-12-13 2008-09-24 ゾーマ テクノロジー リミテッド 改変抗体可変領域の調製のための方法
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
AU6912294A (en) * 1993-05-12 1994-12-12 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
NZ530582A (en) * 2001-07-17 2008-06-30 Res Dev Foundation Therapeutic agents comprising pro-apoptotic proteins, including granzyme, bax and TNF
JP2006506964A (ja) * 2002-06-12 2006-03-02 リサーチ ディベロップメント ファンデーション 治療剤としての免疫毒素及びその利用
SI1551876T1 (sl) 2002-10-16 2011-07-29 Purdue Pharma Lp Protitelesa, ki se vežejo na celično povezan CA 125/0722P, in postopki za njihovo uporabo
CN101132813A (zh) * 2005-02-01 2008-02-27 研究发展基金会 靶向blys受体的blys融合蛋白和用于治疗b细胞增殖性疾病的方法
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
US12595500B2 (en) 2011-09-26 2026-04-07 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
CN103945931B (zh) 2011-09-26 2017-03-22 基因技术股份公司 高效的小体积核酸合成
CA3247166A1 (en) 2012-10-04 2026-03-02 Research Development Foundation Serine protease molecules and therapies
US10563240B2 (en) 2013-03-14 2020-02-18 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
CA3147259A1 (en) 2014-12-09 2016-06-16 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
WO2017062343A1 (en) 2015-10-06 2017-04-13 Pierce Biotechnology, Inc. Devices and methods for producing nucleic acids and proteins
US20210147830A1 (en) 2018-06-29 2021-05-20 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
EP4114972A1 (de) 2020-03-06 2023-01-11 Life Technologies Corporation Nukleinsäuresynthese und -anordnung mit hoher sequenztreue
EP4638776A1 (de) 2022-12-19 2025-10-29 Thermo Fisher Scientific GENEART GmbH Rückgewinnung von sequenzverifizierten nukleinsäuremolekülen
GB2628173A (en) 2023-03-17 2024-09-18 Thermo Fisher Scient Geneart Gmbh Methods of producing modified nucleic acid sequences for eliminating adverse splicing events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
CA2115049C (en) 2003-10-21
IL103057A (en) 1999-09-22
CN1047402C (zh) 1999-12-15
EP0602144B1 (de) 1998-11-04
NO317659B1 (no) 2004-11-29
FI941048A0 (fi) 1994-03-04
EP0602144A4 (de) 1995-03-15
ES2123008T3 (es) 1999-01-01
CN1070227A (zh) 1993-03-24
EP0602144A1 (de) 1994-06-22
IL103057A0 (en) 1993-02-21
RU94034733A (ru) 1996-06-10
DE69227519T2 (de) 1999-06-02
FI113547B (fi) 2004-05-14
NO940736D0 (no) 1994-03-03
DE69227519D1 (de) 1998-12-10
CA2115049A1 (en) 1993-03-18
FI941048L (fi) 1994-03-04
ZA926705B (en) 1993-04-28
WO1993005168A1 (en) 1993-03-18
RU2142015C1 (ru) 1999-11-27
DK0602144T3 (da) 1999-07-19
KR100270195B1 (ko) 2001-03-02
AU2547692A (en) 1993-04-05
NO940736L (no) 1994-03-03
US5624827A (en) 1997-04-29
NZ244220A (en) 1994-12-22
JPH06510431A (ja) 1994-11-24
AU679427B2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
DE69227519D1 (de) Dna-sequenzen kodierend für das polypeptid gelonin
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
EP0756005A4 (de) Für adseverine kodierendes gen
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
NZ241829A (en) Oxalate oxidase, genes encoding it, vectors and transformed plants
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
ZA916171B (en) Protein structure of the plant toxin gelonin
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
IT1254316B (it) Procedimento per la preparazione di acilfosfatasi mediante cellule geneticamente modificate, e vettori ricombinanti ed organismi modificati ottenibili nel procedimento.
TH5997A (th) การสร้างโปรอโปดิโปรโปรตีน a-i ของคนโดยการแสดง?ออกของรหัสพันธุกรรม

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee